期刊文献+

2株H7N9亚型重组禽流感病毒的生物学特性和免疫原性研究 被引量:7

The biological characteristics and immunogenicity of two ressortant H7N9 avian influenza viruses
下载PDF
导出
摘要 为评估经反向遗传构建的H7N9亚型重组禽流感病毒(AIV)H7-Re1株和H7-Re2株的生物学特性及免疫原性,本研究将这2株病毒分别以10^4倍稀释接种10日龄SPF鸡胚后,36℃培养,观察鸡胚存活情况并检测病毒HA效价,结果显示96 h时,2株病毒接种的鸡胚全部存活,培养至72 h时其HA效价均为9 log2,均显著高于亲本分离株。测定2株病毒的静脉内接种致病指数(IVPI),结果显示均为0。将2株病毒分别以10^6 EID50剂量鼻腔内接种5周龄SPF鸡,进行致病性试验,结果显示,接种后14 d内,2株病毒接种鸡均无临床症状,也不排毒。以2株病毒为种毒分别制备油乳剂灭活疫苗,以0.3 mL/只接种3周龄SPF鸡后3周时检测免疫鸡血清中HI抗体,结果显示,两种疫苗免疫鸡平均HI效价均可达到8.0 log2。于免疫后21 d,H7-Re1株免疫组鸡分别攻击10^6 EID50的H7N9亚型低致病力AIV(PG/SHH/S1069/13株)和10^5 EID50的高致病力AIV(CK/GX/SD098/17株),进行攻毒试验,结果显示两种病毒攻毒后免疫鸡均全部存活,且无发病和排毒出现。H7-Re2株免疫组鸡于免疫后21 d分别以10^5 EID50的剂量进行高致病力H7N9亚型AIV(CK/GX/SD098/17株)和H7N2亚型AIV(DK/FJ/SE0195/18株)的攻毒保护试验,结果显示两种病毒攻毒后免疫鸡均不发病、不死亡、不排毒。以上结果表明,以H1N1亚型A/Puerto Rico/8/34株病毒为内部基因供体、经反向遗传学方法构建的H7-Re1株和H7-Re2株均具有生长滴度高、生物安全性高和免疫原性好的特点。本研究为H7N9亚型禽流感疫苗的研制和应用奠定了基础。 To evaluate the biological characteristics and immunogenicity of two ressortant H7N9 avian influenza viruses(H7-Re1 and H7-Re2)generated by reverse genetics,1:10 dilution of these two ressortant viruses were inoculated in 10-day-old chicken embryos,respectively,and cultured at 36℃for 96 hours.All the embryos remained alive during the culturation period and the HA titers of the two viruses in the allantoic fluid both reached up to 9 log2 at 72 hours post inoculation,which showed higher HA titers than those of wild-type viruses.The IVPI values of both two viruses were 0,and 5-week-old SPF chickens survived without any clinical signs or virus shedding after inoculation with 106 EID50 of the two viruses,respectively.One dose(0.3 mL)of inactivated oil-adjuvanted vaccine prepared from H7-Re1 or H7-Re2 ressortant viruses could induce high mean HI antibody titers of≥8 log2 to the vaccine antigen in SPF chickens at 3 weeks post vaccination.When challenged with 10^6 EID50 of the low pathogenic H7N9 virus(PG/SHH/S1069/13)or 10^5 EID50 of lethal H7N9 virus(CK/GX/SD098/17),all the chickens immunized with the H7-Re1 vaccine survived without any clinical signs or virus shedding.The chickens immunized with the vaccine prepared from H7-Re2 virus remained healthy without any virus shedding after challenge with 10^5 EID50 of the lethal H7N9(CK/GX/SD098/17)or H7N2(DK/FJ/SE0195/18)virus.The results showed that H7-Re1 and H7-Re2 ressortant viruses which bear the HA and NA genes from H7N9 viruses and the internal genes from A/Puerto Rico/8/34(H1N1/PR8)virus exhibited high yield in chicken embryos,good biosafety and sound immune efficacy.This study laid the foundation for the development and application of the H7 avian influenza vaccine in poultry.
作者 陈晓涵 吴姣姣 潘舒心 刘艳晶 施建忠 邓国华 包红梅 陈化兰 曾显营 田国彬 CHEN Xiao-han;WU Jiao-jiao;PAN Shu-xin;LIU Yan-jing;SHI Jian-zhong;DENG Guo-hua;BAO Hong-mei;CHEN Hua-lan;ZENG Xian-ying;TIAN Guo-bin(State Key Lab of Veterinary Biotechnology,Harbin Veterinary Research Institute,Chinese Academy of Agricultural Sciences,Harbin 150069,China)
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2020年第9期924-930,共7页 Chinese Journal of Preventive Veterinary Medicine
基金 国家重点研发计划(2017YFD0500701、2016YFD0501602) 现代农业产业技术体系(CARS-41-G12) 农村领域国家科技计划课题(2015BAD12B03/001)。
关键词 禽流感 疫苗种毒 H7-Re1株 H7-Re2株 生物学特性 免疫原性 avian influenza vaccine seed H7-Re1 H7-Re2 biological characteristics immunogenicity
  • 相关文献

参考文献5

二级参考文献37

  • 1CHEN HuaLan Animal Influenza Laboratory of the Ministry of Agriculture and National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150001, China.H5N1 avian influenza in China[J].Science China(Life Sciences),2009,52(5):419-427. 被引量:37
  • 2Li C, Hatta M, Watanabe S, et al. Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses. J Virol, 2008, 82:11880- 11888.
  • 3Holland J, Spindler K, Horodyski F, et al. Rapid evolution of RNA genomes. Science, 1982, 215:1577-1585.
  • 4Yang H, Qiao C, Tang X, et al. Human infection from avian-like in- fluenza A (H1N1) viruses in pigs, China. Emerg Infect Dis, 2012, 18: 1144-1146.
  • 5Hoffmann E, Stech J, Guan Y, et al. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol, 2001, 146:2275-2289.
  • 6Senne D A, Panigrahy B, Kawaoka Y, et al. Survey of the hemagglu- tinin (HA) cleavage site sequence of H5 and H7 avian influenza vi- ruses: Amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis, 1996, 40:425-437.
  • 7Subbarao K, Chen H, Swayne D, et al. Evaluation of a genetically modified reassortant H5N1 influenza a virus vaccine candidate gen- erated by plasmid-based reverse genetics. Virology, 2003, 305: 192- 200.
  • 8Zhang Y, Zhang Q, Gao Y, et al. Key molecular factors in hemagglu- tinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus. J Virol, 2012, 86:9666-9674.
  • 9Chen Z, Zhou H, Kim L, et al. The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets. J Virol, 2012, 86: 2780-2786.
  • 10Naeve C W, Hinshaw V S, Webster R G. Mutations in the hemagglu- tinin receptor-binding site can change the biological properties of an influenza virus. J Virol, 1984, 51:567-569.

共引文献187

同被引文献38

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部